Aim & Scope
The aim of the journal is to critically (without ideological bias) evaluate the current achievements in every field of neuropsychiatry, particularly illness course and treatment effectiveness. It is very important to know how a patient could be defined as improved or recovered, how long a treatment has to last, when therapy works and for whom. These are fundamental issues for Clinical Neuropsychiatry. The main goal of the journal is to collect original papers that directly or indirectly influence the effectiveness of a treatment, particularly focused on Evidence Based Medicine and Clinical Practice. [1]
2024 - VOLUME 21, ISSUE 3
S Brighenti , G Cicinelli , B Urdanch , R Keller
Clinical Neuropsychiatry , 2024 - VOLUME 21, ISSUE 3 , pp 159-168.
0
31
A Narzisi , G Sesso , M Fabbri-Destro , ... , G Masi
Clinical Neuropsychiatry , 2024 - VOLUME 21, ISSUE 3 , pp 169-181.
Review
0
87
Muscle Dysmorphia in Gym-Going Men: The Role of Narcissism Vulnerability and Perfectionism.
HE Kandemir , A Cipriano , MS Rosato , ... , S Cella
Clinical Neuropsychiatry , 2024 - VOLUME 21, ISSUE 3 , pp 182-188.
0
26
Longitudinal Associations Between Resilience and Mental Health During the Covid-19 Pandemic.
V Lenzo , A Sardella , A Musetti , ... , C Franceschini
Clinical Neuropsychiatry , 2024 - VOLUME 21, ISSUE 3 , pp 189-194.
0
13
L Tinella , E Ricciardi , T Cosentino , ... , F Mancini
Clinical Neuropsychiatry , 2024 - VOLUME 21, ISSUE 3 , pp 205-216.
0
30
E Topino , N Pallaoro , M Moyano , ... , A Gori
Clinical Neuropsychiatry , 2024 - VOLUME 21, ISSUE 3 , pp 217-224.
0
49